Quantcast
Last updated on April 24, 2014 at 13:24 EDT

Latest Paul A. Meyers Stories

2005-12-02 15:25:00

NEW YORK (Reuters Health) - Although as many as 70 percent of patients who have the localized stage of the bone cancer osteosarcoma survive after surgery and chemotherapy, the overall survival rate after recurrence is less than 30 percent, researchers report. However, lead investigator Dr. Paul A. Meyers told Reuters Health, "the chances of survival are better for patients whose recurrence is detected after a longer interval from the completion of initial therapy and for patients whose...